Will V940 get approval from the FDA for lung cancer?
5
Ṁ70Ṁ1812030
91%
chance
1H
6H
1D
1W
1M
ALL
V940-002 is a personalized cancer vaccine (Moderna) + pembrolizumab (Merck). The trial (link) is on patients with resected non small cell lung cancer. Will it pass phase 3 and get approval?
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000Sort by:
The trial I linked to is for lung cancer, but V940 is in several other trials as well (see e.g. this press release) - I'm inclined to resolve YES if any of them get approval (and would have said so when I made this market), but I realize it's very old so if anyone objects to me changing the criteria now say so.
People are also trading
Related questions
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
13% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
19% chance
Will Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2026?
3% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
26% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will dt120 get fda approval before 2029
61% chance
Will FDA approve any mRNA vaccine against stomach adenocarcinoma before 2028?
30% chance